Do analysts prefer TACT or QMCO?

Quantum has a consensus price target of $17.67, indicating a potential upside of 11.96%. Given Quantum's stronger consensus rating and higher possible upside, analysts plainly believe Quantum is more favorable than TransAct Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Quantum 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media prefer TACT or QMCO?

In the previous week, TransAct Technologies had 9 more articles in the media than Quantum. MarketBeat recorded 12 mentions for TransAct Technologies and 3 mentions for Quantum. TransAct Technologies' average media sentiment score of 1.13 beat Quantum's score of 0.31 indicating that TransAct Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quantum 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate TACT or ZEPP?

Zepp Health has a consensus target price of $56.28, suggesting a potential upside of 768.12%. Given Zepp Health's stronger consensus rating and higher possible upside, analysts clearly believe Zepp Health is more favorable than TransAct Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Zepp Health 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor TACT or ZEPP?

In the previous week, TransAct Technologies had 11 more articles in the media than Zepp Health. MarketBeat recorded 12 mentions for TransAct Technologies and 1 mentions for Zepp Health. TransAct Technologies' average media sentiment score of 1.13 beat Zepp Health's score of 0.00 indicating that TransAct Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend TACT or ALOT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 AstroNova 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer INVE or TACT?

Identiv presently has a consensus target price of $6.33, indicating a potential upside of 47.63%. Given Identiv's stronger consensus rating and higher probable upside, equities analysts clearly believe Identiv is more favorable than TransAct Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Identiv 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to INVE or TACT?

In the previous week, TransAct Technologies had 10 more articles in the media than Identiv. MarketBeat recorded 12 mentions for TransAct Technologies and 2 mentions for Identiv. TransAct Technologies' average media sentiment score of 1.13 beat Identiv's score of 0.85 indicating that TransAct Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Identiv 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TACT or VTIX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Virtuix 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has higher earnings and valuation, TACT or VTIX?

Virtuix has lower revenue, but higher earnings than TransAct Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransAct Technologies $52.84M 0.91 -$1.24M -$0.05 N/A Virtuix $4.46M 24.03 N/A N/A N/A

Does the media prefer TACT or VTIX?

In the previous week, TransAct Technologies had 7 more articles in the media than Virtuix. MarketBeat recorded 12 mentions for TransAct Technologies and 5 mentions for Virtuix. TransAct Technologies' average media sentiment score of 1.13 beat Virtuix's score of 0.39 indicating that TransAct Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Virtuix 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

TransAct Technologies (TACT) Competitors

$4.66 +0.10 (+2.19%)

Closing price 04:00 PM Eastern

Extended Trading

$4.68 +0.02 (+0.54%)

As of 04:10 PM Eastern

Compare

TACT vs. QMCO, ZEPP, ALOT, INVE, and VTIX

Should you buy TransAct Technologies stock or one of its competitors? MarketBeat compares TransAct Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TransAct Technologies include Quantum (QMCO), Zepp Health (ZEPP), AstroNova (ALOT), Identiv (INVE), and Virtuix (VTIX). These companies are all part of the "computer hardware" industry.

How does TransAct Technologies compare to Quantum?

TransAct Technologies (NASDAQ:TACT) and Quantum (NASDAQ:QMCO) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

TransAct Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, Quantum has a beta of 2.97, suggesting that its share price is 197% more volatile than the broader market.

In the previous week, TransAct Technologies had 9 more articles in the media than Quantum. MarketBeat recorded 12 mentions for TransAct Technologies and 3 mentions for Quantum. TransAct Technologies' average media sentiment score of 1.13 beat Quantum's score of 0.31 indicating that TransAct Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quantum	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TransAct Technologies has a net margin of -0.93% compared to Quantum's net margin of -37.76%. Quantum's return on equity of 0.00% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.93%	-1.56%	-1.08%
Quantum	-37.76%	N/A	-21.66%

TransAct Technologies has higher earnings, but lower revenue than Quantum. TransAct Technologies is trading at a lower price-to-earnings ratio than Quantum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$52.84M	0.91	-$1.24M	-$0.05	N/A
Quantum	$274.06M	0.84	-$115.09M	-$2.36	N/A

Quantum has a consensus price target of $17.67, indicating a potential upside of 11.96%. Given Quantum's stronger consensus rating and higher possible upside, analysts plainly believe Quantum is more favorable than TransAct Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Quantum	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

74.5% of TransAct Technologies shares are owned by institutional investors. Comparatively, 63.7% of Quantum shares are owned by institutional investors. 19.2% of TransAct Technologies shares are owned by insiders. Comparatively, 0.9% of Quantum shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

TransAct Technologies beats Quantum on 9 of the 16 factors compared between the two stocks.

How does TransAct Technologies compare to Zepp Health?

TransAct Technologies (NASDAQ:TACT) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

74.5% of TransAct Technologies shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 19.2% of TransAct Technologies shares are held by company insiders. Comparatively, 36.0% of Zepp Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

TransAct Technologies has higher earnings, but lower revenue than Zepp Health. TransAct Technologies is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$52.84M	0.91	-$1.24M	-$0.05	N/A
Zepp Health	$258.90M	0.37	-$40.07M	-$2.51	N/A

Zepp Health has a consensus target price of $56.28, suggesting a potential upside of 768.12%. Given Zepp Health's stronger consensus rating and higher possible upside, analysts clearly believe Zepp Health is more favorable than TransAct Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, TransAct Technologies had 11 more articles in the media than Zepp Health. MarketBeat recorded 12 mentions for TransAct Technologies and 1 mentions for Zepp Health. TransAct Technologies' average media sentiment score of 1.13 beat Zepp Health's score of 0.00 indicating that TransAct Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TransAct Technologies has a net margin of -0.93% compared to Zepp Health's net margin of -15.48%. TransAct Technologies' return on equity of -1.56% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.93%	-1.56%	-1.08%
Zepp Health	-15.48%	-15.00%	-6.07%

TransAct Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Zepp Health has a beta of 1.78, meaning that its stock price is 78% more volatile than the broader market.

Summary

TransAct Technologies beats Zepp Health on 9 of the 16 factors compared between the two stocks.

How does TransAct Technologies compare to AstroNova?

TransAct Technologies (NASDAQ:TACT) and AstroNova (NASDAQ:ALOT) are both small-cap computer hardware companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends.

TransAct Technologies has higher earnings, but lower revenue than AstroNova. TransAct Technologies is trading at a lower price-to-earnings ratio than AstroNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$52.84M	0.91	-$1.24M	-$0.05	N/A
AstroNova	$150.51M	0.78	-$2.38M	-$0.31	N/A

74.5% of TransAct Technologies shares are owned by institutional investors. Comparatively, 43.0% of AstroNova shares are owned by institutional investors. 19.2% of TransAct Technologies shares are owned by insiders. Comparatively, 12.6% of AstroNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
AstroNova	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

TransAct Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, AstroNova has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

In the previous week, TransAct Technologies had 12 more articles in the media than AstroNova. MarketBeat recorded 12 mentions for TransAct Technologies and 0 mentions for AstroNova. TransAct Technologies' average media sentiment score of 1.13 beat AstroNova's score of 0.62 indicating that TransAct Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
TransAct Technologies	Positive
AstroNova	Positive

TransAct Technologies has a net margin of -0.93% compared to AstroNova's net margin of -1.58%. AstroNova's return on equity of 1.53% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.93%	-1.56%	-1.08%
AstroNova	-1.58%	1.53%	0.82%

Summary

TransAct Technologies beats AstroNova on 10 of the 14 factors compared between the two stocks.

How does TransAct Technologies compare to Identiv?

Identiv (NASDAQ:INVE) and TransAct Technologies (NASDAQ:TACT) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

Identiv has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, TransAct Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market.

Identiv presently has a consensus target price of $6.33, indicating a potential upside of 47.63%. Given Identiv's stronger consensus rating and higher probable upside, equities analysts clearly believe Identiv is more favorable than TransAct Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Identiv	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, TransAct Technologies had 10 more articles in the media than Identiv. MarketBeat recorded 12 mentions for TransAct Technologies and 2 mentions for Identiv. TransAct Technologies' average media sentiment score of 1.13 beat Identiv's score of 0.85 indicating that TransAct Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Identiv	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransAct Technologies has higher revenue and earnings than Identiv. TransAct Technologies is trading at a lower price-to-earnings ratio than Identiv, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Identiv	$21.48M	4.80	-$18M	-$0.72	N/A
TransAct Technologies	$52.84M	0.91	-$1.24M	-$0.05	N/A

65.2% of Identiv shares are held by institutional investors. Comparatively, 74.5% of TransAct Technologies shares are held by institutional investors. 3.6% of Identiv shares are held by insiders. Comparatively, 19.2% of TransAct Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

TransAct Technologies has a net margin of -0.93% compared to Identiv's net margin of -70.52%. TransAct Technologies' return on equity of -1.56% beat Identiv's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Identiv	-70.52%	-11.74%	-11.04%
TransAct Technologies	-0.93%	-1.56%	-1.08%

Summary

TransAct Technologies beats Identiv on 11 of the 16 factors compared between the two stocks.

How does TransAct Technologies compare to Virtuix?

TransAct Technologies (NASDAQ:TACT) and Virtuix (NASDAQ:VTIX) are both small-cap computer hardware companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Virtuix has lower revenue, but higher earnings than TransAct Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$52.84M	0.91	-$1.24M	-$0.05	N/A
Virtuix	$4.46M	24.03	N/A	N/A	N/A

In the previous week, TransAct Technologies had 7 more articles in the media than Virtuix. MarketBeat recorded 12 mentions for TransAct Technologies and 5 mentions for Virtuix. TransAct Technologies' average media sentiment score of 1.13 beat Virtuix's score of 0.39 indicating that TransAct Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Virtuix	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

74.5% of TransAct Technologies shares are held by institutional investors. 19.2% of TransAct Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Virtuix has a net margin of 0.00% compared to TransAct Technologies' net margin of -0.93%. Virtuix's return on equity of 0.00% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.93%	-1.56%	-1.08%
Virtuix	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Virtuix	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

TransAct Technologies beats Virtuix on 5 of the 9 factors compared between the two stocks.

Get TransAct Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TACT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TACT vs. The Competition

Export

Metric	TransAct Technologies	COMP Industry	Computer Sector	NASDAQ Exchange
Market Cap	$47.89M	$2.17B	$40.50B	$12.46B
Dividend Yield	N/A	4.34%	3.06%	5.22%
P/E Ratio	-93.20	85.93	82.27	24.36
Price / Sales	0.91	6.34	636.66	117.06
Price / Cash	N/A	7.02	53.03	57.13
Price / Book	1.51	3.04	10.17	6.73
Net Income	-$1.24M	$84.65M	$1.06B	$337.03M
7 Day Performance	6.88%	6.35%	2.38%	0.08%
1 Month Performance	N/A	N/A	N/A	-1.78%
1 Year Performance	31.64%	14.56%	170.08%	33.98%

TransAct Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TACT TransAct Technologies	1.3519 of 5 stars	$4.66 +2.2%	N/A	+24.9%	$47.89M	$52.84M	N/A	120	Trending News Analyst Revision
QMCO Quantum	2.3869 of 5 stars	$8.73 -3.5%	$13.67 +56.5%	+34.3%	$132.47M	$274.06M	N/A	900	Analyst Forecast Gap Down
ZEPP Zepp Health	2.7385 of 5 stars	$8.86 +2.8%	$56.28 +535.2%	+181.0%	$126.54M	$258.90M	N/A	1,230	Upcoming Earnings
ALOT AstroNova	0.461 of 5 stars	$14.11 -0.8%	N/A	+67.7%	$109.47M	$150.52M	N/A	340
INVE Identiv	3.312 of 5 stars	$3.93 -2.5%	$6.33 +61.2%	+29.2%	$96.75M	$21.48M	N/A	330

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TACT) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TransAct Technologies (TACT) Competitors

TACT vs. QMCO, ZEPP, ALOT, INVE, and VTIX

How does TransAct Technologies compare to Quantum?

Summary

How does TransAct Technologies compare to Zepp Health?

Summary

How does TransAct Technologies compare to AstroNova?

Summary

How does TransAct Technologies compare to Identiv?

Summary

How does TransAct Technologies compare to Virtuix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACT vs. The Competition

TransAct Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TransAct Technologies (TACT) Competitors

TACT vs. QMCO, ZEPP, ALOT, INVE, and VTIX

How does TransAct Technologies compare to Quantum?

Which has more risk & volatility, TACT or QMCO?

Does the media prefer TACT or QMCO?

Is TACT or QMCO more profitable?

Which has better earnings & valuation, TACT or QMCO?

Do analysts prefer TACT or QMCO?

Do institutionals & insiders believe in TACT or QMCO?

Summary

How does TransAct Technologies compare to Zepp Health?

Do insiders and institutionals have more ownership in TACT or ZEPP?

Which has stronger earnings & valuation, TACT or ZEPP?

Do analysts rate TACT or ZEPP?

Does the media favor TACT or ZEPP?

Is TACT or ZEPP more profitable?

Which has more volatility and risk, TACT or ZEPP?

Summary

How does TransAct Technologies compare to AstroNova?

Which has stronger valuation and earnings, TACT or ALOT?

Do insiders & institutionals have more ownership in TACT or ALOT?

Do analysts recommend TACT or ALOT?

Which has more volatility and risk, TACT or ALOT?

Does the media prefer TACT or ALOT?

Is TACT or ALOT more profitable?

Summary

How does TransAct Technologies compare to Identiv?

Which has more risk & volatility, INVE or TACT?

Do analysts prefer INVE or TACT?

Does the media refer more to INVE or TACT?

Which has stronger earnings & valuation, INVE or TACT?

Do insiders and institutionals believe in INVE or TACT?

Is INVE or TACT more profitable?

Summary

How does TransAct Technologies compare to Virtuix?

Which has higher earnings and valuation, TACT or VTIX?

Does the media prefer TACT or VTIX?

Do insiders & institutionals hold more shares of TACT or VTIX?

Is TACT or VTIX more profitable?

Do analysts rate TACT or VTIX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACT vs. The Competition

TransAct Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools